DERIVATIVES OF DIALKYL ETHER, (PHARMACEUTICAL COMPOSITION) Russian patent published in 2002 - IPC

Abstract RU 2191772 C2

FIELD: Organic chemistry, medicine, pharmacy. SUBSTANCE: Invention describes novel derivatives of dialkyl ether of the general formula (1) given in the invention description where n and m mean independently each of other whole numbers from 2 to 6; R1,R2,R3R4 mean independently each of other alkyl with carbon atom numbers from one to six; Y1 and Y2 mean independently each of other carboxyl group or group COOR5 where R5 means alkyl with carbon atom numbers from one to six. Indicated compounds are used in pharmaceutical composition eliciting activity with respect to decrease of plasma level of lipoprotein (a), apolipoprotein B, triglycerides, cholesterol complex with lipoproteins of low and very low density and with respect to increase of plasma level of apolipoprotein A-1 or E, cholesterol complex with lipoproteins of high density. Invention describes also method of decrease of plasma level of lipoprotein (a), apolipoprotein B, triglycerides, cholesterol complex with lipoproteins of low or very low density by administration effective dose of compound of the formula (1) as active substance and method of increase of plasma level of cholesterol complex with lipoproteins of high density or apolipoproteins A-1 and E by administration of effective dose of compound of the formula (1) as active substance. Invention describes also method of prophylaxis or treatment of disease of vessels and method of prophylaxis or treatment of insulin-nondependent diabetes mellitus by administration of compound of the general formula (1) as active substance. EFFECT: improved method of treatment and prophylaxis, valuable medicinal properties of compounds. 22 cl, 40 dwg, 12 ex

Similar patents RU2191772C2

Title Year Author Number
SULFAMIC ACID ESTERS, PHARMACEUTICAL COMPOSITION FOR CONTROL OF CHOLESTEROL CONCENTRATION, METHOD OF TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA, METHOD OF TREATMENT OF PATIENTS WITH ATHEROSCLEROSIS 1994
  • Khelen Tsenvej Li
  • Dzhozef Armend Pikard
  • Drago Robert Sliskovits
  • Vendell Virendzhe
RU2137756C1
DERIVATIVES OF BENZOTHIOPHENE, BENZOFURAN, INDOLETHIAZEPINONE, OXAZEPINONE AND DIAZEPINONE, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY INHIBITING CELLULAR ADHESION OR HIV-ACTIVITY, METHOD OF INHIBITION OF LEUKOCYTE ADHESION TO ENDOTHELIAL CELLS IN TREATMENT OF DISEASES CAUSED WITH ITS, METHOD OF TREATMENT OF MAMMALS INFECTED WITH HIV-INFECTION 1995
  • Dajehn Khehrris Boskelli
  • Dejvid Tomehs Konnor
  • Dzhejmz Bernard Krejmer
  • Pol Charlz Anehngst
RU2144033C1
METHOD OF TREATMENT OF PATIENTS WITH FEAR STATE OR TREATMENT AND/OR PROPHYLAXIS OF PANIC STATE, PURIFIED PROTEIN ABLE TO BIND GABAPENTIN AND PHARMACEUTICAL COMPOSITION SHOWING SEDATIVE, ANTIPANIC AND ANTICONVULSANT EFFECTS 1995
  • Vudraff Dzhoffri Nil
  • Dzhi Nikolas S.
  • Zing Lakbir
  • Braun Dzhejson P.
RU2168982C2
DERIVATIVES OF 3-ALKYLHYDROXY-, ARYLHYDROXY- OR ARYLALKYLHYDROXY[B]THIOPHENE-2-CARBOXAMIDE, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY INHIBITING ADHESION OF LEUKOCYTES TO VASCULAR ENDOTHELIUM 1993
  • Dajen Khehrris Boskelli
  • Dehvid Tomas Konnor
  • Klifford Din Rajt
RU2117665C1
METHOD OF PRODUCING SALTS OF 4'-(9-ACRIDINYLAMINO)-METHANSULFON-M-ANISIDINE 0
  • Dzhejms R.Fisher
  • Charlz P.Kulir
SU1192619A3
METHODS AND COMPOSITION FOR DECREASING LIPOPROTEIN (a) CONTENT IN PLASMA AND REDUCING FACTORS FOR RISK OF CARDIOVASCULAR DISEASES 2001
  • Rat Mattias
RU2289406C2
METHOD OF PRODUCING NAPHTHYLIDIENE AND QUINOLINE COMPOUNDS 0
  • Tomas Frederik Mich
SU1192624A3
SUBSTITUTED 1,2,3,4-TETRAHYDROISOQUINOLINES, INTERMEDIATE COMPOUNDS AND PHARMCOMPOSITION 1993
  • Klifton Dzhon Blehnklej
  • Dzhon Kuk Khodges
  • Sil'Vester Klachko
RU2135473C1
METHOD OF PREPARING TRANS-6-[SUBSTITUTED PYRROL-1- YL)ALKYL]PYRAN-2-ON DERIVATIVES AND THEIR DIHYDROXY-CONTAINING ACIDS AND SALTS, HYDROXY-, 1,3-DIOXAN- OR PYRROLE-CONTAINING CARBOXYLIC ACIDS AS INTERMEDIATES FOR PREPARING SAID PYRAN-2-ON DERIVATIVES 1994
  • Donal'D Ehjdzhin Batler
  • Tung Van Li
  • Tomas Norman Nanninga
RU2138497C1
USE OF 2-PHENYL-3-AROYLBENZOTHIOPHENES FOR SERUM BLOOD CHOLESTEROL DECREASE, PHARMACEUTICAL COMPOSITION 1995
  • Majkl Uil'Jam Drejper
RU2150275C1

RU 2 191 772 C2

Authors

Bisgajer Charl'Z Larri

Kreger Pol' Leroj

Saltiel Alan Robert

Tafuri Sherri Ri

Dates

2002-10-27Published

1996-02-05Filed